 | • レポートコード：D0804-16788 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、トポテカンの世界市場を広く調査・分析し、今後の市場展望をまとめております。トポテカンの種類別市場規模（注射、カプセル）、用途別市場規模（小細胞肺がん、転移性卵巣がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ark Pharm、Sichuan Keruide Kaihua Pharmaceutical、Nanjing Ruinian Best Pharmaceutical、GSK、Jiangsu Hengrui Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Grand Pharmaceutical、Guizhou Hanfang Pharmaceutical、Yangtze Pharmaceutical Group ・地域別グローバル市場分析 2015年-2020年 ・トポテカンの北米市場（アメリカ、カナダ、メキシコ） ・トポテカンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・トポテカンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・トポテカンの南米市場（ブラジル、アルゼンチン） ・トポテカンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、カプセル ・用途別分析：小細胞肺がん、転移性卵巣がん ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Topotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Topotecan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Topotecan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Topotecan market has been segmented into:
Injection
Capsule
By Application, Topotecan has been segmented into:
Small Cell Lung Cancer
Metastatic Advanced Ovarian Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Topotecan market presented in the report. This section sheds light on the sales growth of different regional and country-level Topotecan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Topotecan market.
The report offers in-depth assessment of the growth and other aspects of the Topotecan market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Topotecan Market Share Analysis
Topotecan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Topotecan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Topotecan sales, revenue and market share for each player covered in this report.
The major players covered in Topotecan are:
Ark Pharm
Sichuan Keruide Kaihua Pharmaceutical
Nanjing Ruinian Best Pharmaceutical
GSK
Jiangsu Hengrui Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Grand Pharmaceutical
Guizhou Hanfang Pharmaceutical
Yangtze Pharmaceutical Group
Table of Contents
1 Topotecan Market Overview
1.1 Product Overview and Scope of Topotecan
1.2 Classification of Topotecan by Type
1.2.1 Global Topotecan Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Topotecan Revenue Market Share by Type in 2019
1.2.3 Injection
1.2.4 Capsule
1.3 Global Topotecan Market by Application
1.3.1 Overview: Global Topotecan Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Small Cell Lung Cancer
1.3.3 Metastatic Advanced Ovarian Cancer
1.4 Global Topotecan Market by Regions
1.4.1 Global Topotecan Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Topotecan (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Topotecan Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Topotecan Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Topotecan Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Topotecan Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Topotecan Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ark Pharm
2.1.1 Ark Pharm Details
2.1.2 Ark Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ark Pharm SWOT Analysis
2.1.4 Ark Pharm Product and Services
2.1.5 Ark Pharm Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sichuan Keruide Kaihua Pharmaceutical
2.2.1 Sichuan Keruide Kaihua Pharmaceutical Details
2.2.2 Sichuan Keruide Kaihua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sichuan Keruide Kaihua Pharmaceutical SWOT Analysis
2.2.4 Sichuan Keruide Kaihua Pharmaceutical Product and Services
2.2.5 Sichuan Keruide Kaihua Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nanjing Ruinian Best Pharmaceutical
2.3.1 Nanjing Ruinian Best Pharmaceutical Details
2.3.2 Nanjing Ruinian Best Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nanjing Ruinian Best Pharmaceutical SWOT Analysis
2.3.4 Nanjing Ruinian Best Pharmaceutical Product and Services
2.3.5 Nanjing Ruinian Best Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.5 Jiangsu Hengrui Pharmaceutical
2.5.1 Jiangsu Hengrui Pharmaceutical Details
2.5.2 Jiangsu Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Jiangsu Hengrui Pharmaceutical SWOT Analysis
2.5.4 Jiangsu Hengrui Pharmaceutical Product and Services
2.5.5 Jiangsu Hengrui Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.6 Jiangsu Aosaikang Pharmaceutical
2.6.1 Jiangsu Aosaikang Pharmaceutical Details
2.6.2 Jiangsu Aosaikang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Jiangsu Aosaikang Pharmaceutical SWOT Analysis
2.6.4 Jiangsu Aosaikang Pharmaceutical Product and Services
2.6.5 Jiangsu Aosaikang Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.7 Grand Pharmaceutical
2.7.1 Grand Pharmaceutical Details
2.7.2 Grand Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Grand Pharmaceutical SWOT Analysis
2.7.4 Grand Pharmaceutical Product and Services
2.7.5 Grand Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.8 Guizhou Hanfang Pharmaceutical
2.8.1 Guizhou Hanfang Pharmaceutical Details
2.8.2 Guizhou Hanfang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Guizhou Hanfang Pharmaceutical SWOT Analysis
2.8.4 Guizhou Hanfang Pharmaceutical Product and Services
2.8.5 Guizhou Hanfang Pharmaceutical Topotecan Revenue, Gross Margin and Market Share (2018-2019)
2.9 Yangtze Pharmaceutical Group
2.9.1 Yangtze Pharmaceutical Group Details
2.9.2 Yangtze Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Yangtze Pharmaceutical Group SWOT Analysis
2.9.4 Yangtze Pharmaceutical Group Product and Services
2.9.5 Yangtze Pharmaceutical Group Topotecan Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Topotecan Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Topotecan Players Market Share
3.2.2 Top 10 Topotecan Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Topotecan Revenue and Market Share by Regions
4.2 North America Topotecan Revenue and Growth Rate (2015-2020)
4.3 Europe Topotecan Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Topotecan Revenue and Growth Rate (2015-2020)
4.5 South America Topotecan Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Topotecan Revenue and Growth Rate (2015-2020)
5 North America Topotecan Revenue by Countries
5.1 North America Topotecan Revenue by Countries (2015-2020)
5.2 USA Topotecan Revenue and Growth Rate (2015-2020)
5.3 Canada Topotecan Revenue and Growth Rate (2015-2020)
5.4 Mexico Topotecan Revenue and Growth Rate (2015-2020)
6 Europe Topotecan Revenue by Countries
6.1 Europe Topotecan Revenue by Countries (2015-2020)
6.2 Germany Topotecan Revenue and Growth Rate (2015-2020)
6.3 UK Topotecan Revenue and Growth Rate (2015-2020)
6.4 France Topotecan Revenue and Growth Rate (2015-2020)
6.5 Russia Topotecan Revenue and Growth Rate (2015-2020)
6.6 Italy Topotecan Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Topotecan Revenue by Countries
7.1 Asia-Pacific Topotecan Revenue by Countries (2015-2020)
7.2 China Topotecan Revenue and Growth Rate (2015-2020)
7.3 Japan Topotecan Revenue and Growth Rate (2015-2020)
7.4 Korea Topotecan Revenue and Growth Rate (2015-2020)
7.5 India Topotecan Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Topotecan Revenue and Growth Rate (2015-2020)
8 South America Topotecan Revenue by Countries
8.1 South America Topotecan Revenue by Countries (2015-2020)
8.2 Brazil Topotecan Revenue and Growth Rate (2015-2020)
8.3 Argentina Topotecan Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Topotecan by Countries
9.1 Middle East & Africa Topotecan Revenue by Countries (2015-2020)
9.2 Saudi Arabia Topotecan Revenue and Growth Rate (2015-2020)
9.3 UAE Topotecan Revenue and Growth Rate (2015-2020)
9.4 Egypt Topotecan Revenue and Growth Rate (2015-2020)
9.5 South Africa Topotecan Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Topotecan Revenue and Market Share by Type (2015-2020)
10.2 Global Topotecan Market Forecast by Type (2019-2024)
10.3 Injection Revenue Growth Rate (2015-2025)
10.4 Capsule Revenue Growth Rate (2015-2025)
11 Global Topotecan Market Segment by Application
11.1 Global Topotecan Revenue Market Share by Application (2015-2020)
11.2 Topotecan Market Forecast by Application (2019-2024)
11.3 Small Cell Lung Cancer Revenue Growth (2015-2020)
11.4 Metastatic Advanced Ovarian Cancer Revenue Growth (2015-2020)
12 Global Topotecan Market Size Forecast (2021-2025)
12.1 Global Topotecan Market Size Forecast (2021-2025)
12.2 Global Topotecan Market Forecast by Regions (2021-2025)
12.3 North America Topotecan Revenue Market Forecast (2021-2025)
12.4 Europe Topotecan Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Topotecan Revenue Market Forecast (2021-2025)
12.6 South America Topotecan Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Topotecan Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Topotecan Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Topotecan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Topotecan Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Topotecan Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Ark Pharm Corporate Information, Location and Competitors
Table 6. Ark Pharm Topotecan Major Business
Table 7. Ark Pharm Topotecan Total Revenue (USD Million) (2017-2018)
Table 8. Ark Pharm SWOT Analysis
Table 9. Ark Pharm Topotecan Product and Solutions
Table 10. Ark Pharm Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sichuan Keruide Kaihua Pharmaceutical Corporate Information, Location and Competitors
Table 12. Sichuan Keruide Kaihua Pharmaceutical Topotecan Major Business
Table 13. Sichuan Keruide Kaihua Pharmaceutical Topotecan Total Revenue (USD Million) (2018-2019)
Table 14. Sichuan Keruide Kaihua Pharmaceutical SWOT Analysis
Table 15. Sichuan Keruide Kaihua Pharmaceutical Topotecan Product and Solutions
Table 16. Sichuan Keruide Kaihua Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Nanjing Ruinian Best Pharmaceutical Corporate Information, Location and Competitors
Table 18. Nanjing Ruinian Best Pharmaceutical Topotecan Major Business
Table 19. Nanjing Ruinian Best Pharmaceutical Topotecan Total Revenue (USD Million) (2017-2018)
Table 20. Nanjing Ruinian Best Pharmaceutical SWOT Analysis
Table 21. Nanjing Ruinian Best Pharmaceutical Topotecan Product and Solutions
Table 22. Nanjing Ruinian Best Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GSK Corporate Information, Location and Competitors
Table 24. GSK Topotecan Major Business
Table 25. GSK Topotecan Total Revenue (USD Million) (2017-2018)
Table 26. GSK SWOT Analysis
Table 27. GSK Topotecan Product and Solutions
Table 28. GSK Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Jiangsu Hengrui Pharmaceutical Corporate Information, Location and Competitors
Table 30. Jiangsu Hengrui Pharmaceutical Topotecan Major Business
Table 31. Jiangsu Hengrui Pharmaceutical Topotecan Total Revenue (USD Million) (2017-2018)
Table 32. Jiangsu Hengrui Pharmaceutical SWOT Analysis
Table 33. Jiangsu Hengrui Pharmaceutical Topotecan Product and Solutions
Table 34. Jiangsu Hengrui Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Jiangsu Aosaikang Pharmaceutical Corporate Information, Location and Competitors
Table 36. Jiangsu Aosaikang Pharmaceutical Topotecan Major Business
Table 37. Jiangsu Aosaikang Pharmaceutical Topotecan Total Revenue (USD Million) (2017-2018)
Table 38. Jiangsu Aosaikang Pharmaceutical SWOT Analysis
Table 39. Jiangsu Aosaikang Pharmaceutical Topotecan Product and Solutions
Table 40. Jiangsu Aosaikang Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Grand Pharmaceutical Corporate Information, Location and Competitors
Table 42. Grand Pharmaceutical Topotecan Major Business
Table 43. Grand Pharmaceutical Topotecan Total Revenue (USD Million) (2017-2018)
Table 44. Grand Pharmaceutical SWOT Analysis
Table 45. Grand Pharmaceutical Topotecan Product and Solutions
Table 46. Grand Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Guizhou Hanfang Pharmaceutical Corporate Information, Location and Competitors
Table 48. Guizhou Hanfang Pharmaceutical Topotecan Major Business
Table 49. Guizhou Hanfang Pharmaceutical Topotecan Total Revenue (USD Million) (2017-2018)
Table 50. Guizhou Hanfang Pharmaceutical SWOT Analysis
Table 51. Guizhou Hanfang Pharmaceutical Topotecan Product and Solutions
Table 52. Guizhou Hanfang Pharmaceutical Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Yangtze Pharmaceutical Group Corporate Information, Location and Competitors
Table 54. Yangtze Pharmaceutical Group Topotecan Major Business
Table 55. Yangtze Pharmaceutical Group Topotecan Total Revenue (USD Million) (2017-2018)
Table 56. Yangtze Pharmaceutical Group SWOT Analysis
Table 57. Yangtze Pharmaceutical Group Topotecan Product and Solutions
Table 58. Yangtze Pharmaceutical Group Topotecan Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Topotecan Revenue (Million USD) by Players (2015-2020)
Table 60. Global Topotecan Revenue Share by Players (2015-2020)
Table 61. Global Topotecan Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Topotecan Revenue Market Share by Regions (2015-2020)
Table 63. North America Topotecan Revenue by Countries (2015-2020)
Table 64. North America Topotecan Revenue Market Share by Countries (2015-2020)
Table 65. Europe Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Topotecan Revenue by Countries (2015-2020)
Table 68. South America Topotecan Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Topotecan Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Topotecan Revenue Market Share by Countries (2015-2020)
Table 71. Global Topotecan Revenue (Million USD) by Type (2015-2020)
Table 72. Global Topotecan Revenue Share by Type (2015-2020)
Table 73. Global Topotecan Revenue Forecast by Type (2021-2025)
Table 74. Global Topotecan Revenue by Application (2015-2020)
Table 75. Global Topotecan Revenue Share by Application (2015-2020)
Table 76. Global Topotecan Revenue Forecast by Application (2021-2025)
Table 77. Global Topotecan Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Topotecan Picture
Figure 2. Global Topotecan Revenue Market Share by Type in 2019
Figure 3. Injection Picture
Figure 4. Capsule Picture
Figure 5. Topotecan Revenue Market Share by Application in 2019
Figure 6. Small Cell Lung Cancer Picture
Figure 7. Metastatic Advanced Ovarian Cancer Picture
Figure 8. Global Topotecan Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Topotecan Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Topotecan Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Topotecan Revenue Market Share in 2019
Figure 17. Global Top 10 Players Topotecan Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Topotecan Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Topotecan Revenue Market Share by Regions (2015-2020)
Figure 21. Global Topotecan Revenue Market Share by Regions in 2018
Figure 22. North America Topotecan Revenue and Growth Rate (2015-2020)
Figure 23. Europe Topotecan Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Topotecan Revenue and Growth Rate (2015-2020)
Figure 25. South America Topotecan Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Topotecan Revenue and Growth Rate (2015-2020)
Figure 27. North America Topotecan Revenue Market Share by Countries (2015-2020)
Figure 28. North America Topotecan Revenue Market Share by Countries in 2019
Figure 29. USA Topotecan Revenue and Growth Rate (2015-2020)
Figure 30. Canada Topotecan Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Topotecan Revenue and Growth Rate (2015-2020)
Figure 32. Europe Topotecan Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Topotecan Revenue Market Share by Countries in 2019
Figure 34. Germany Topotecan Revenue and Growth Rate (2015-2020)
Figure 35. UK Topotecan Revenue and Growth Rate (2015-2020)
Figure 36. France Topotecan Revenue and Growth Rate (2015-2020)
Figure 37. Russia Topotecan Revenue and Growth Rate (2015-2020)
Figure 38. Italy Topotecan Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Topotecan Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Topotecan Revenue Market Share by Countries in 2019
Figure 41. China Topotecan Revenue and Growth Rate (2015-2020)
Figure 42. Japan Topotecan Revenue and Growth Rate (2015-2020)
Figure 43. Korea Topotecan Revenue and Growth Rate (2015-2020)
Figure 44. India Topotecan Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Topotecan Revenue and Growth Rate (2015-2020)
Figure 46. South America Topotecan Revenue Market Share by Countries (2015-2020)
Figure 47. South America Topotecan Revenue Market Share by Countries in 2019
Figure 48. Brazil Topotecan Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Topotecan Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Topotecan Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Topotecan Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Topotecan Revenue and Growth Rate (2015-2020)
Figure 53. UAE Topotecan Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Topotecan Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Topotecan Revenue and Growth Rate (2015-2020)
Figure 56. Global Topotecan Revenue Share by Type (2015-2020)
Figure 57. Global Topotecan Revenue Share by Type in 2019
Figure 58. Global Topotecan Market Share Forecast by Type (2021-2025)
Figure 59. Global Injection Revenue Growth Rate (2015-2020)
Figure 60. Global Capsule Revenue Growth Rate (2015-2020)
Figure 61. Global Topotecan Revenue Share by Application (2015-2020)
Figure 62. Global Topotecan Revenue Share by Application in 2019
Figure 63. Global Topotecan Market Share Forecast by Application (2021-2025)
Figure 64. Global Small Cell Lung Cancer Revenue Growth Rate (2015-2020)
Figure 65. Global Metastatic Advanced Ovarian Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Topotecan Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Topotecan Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Topotecan Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Topotecan Revenue Market Forecast (2021-2025)
Figure 70. Europe Topotecan Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Topotecan Revenue Market Forecast (2021-2025)
Figure 72. South America Topotecan Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Topotecan Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
非小細胞肺がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drugs for Non-small Cell Lung Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs fo…- 転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…
- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 腫瘍溶解性ウイルスがん免疫療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Cancer Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolyti…
- がん幹細胞（CSC）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Stem Cells (CSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Stem Cells (C…